About me

Joan Clària is the group leader of the Inflammation and Liver Disease group at IDIBAPS. He is a clinical biochemist specialist by training at the Biochemistry and Molecular Genetics Service of the Hospital Clínic of Barcelona and Professor at the Department of Biomedical Sciences of the University of Barcelona. He performed post-doctoral studies at the Brigham and Women's Hospital (1993-1996) and appointed as visiting professor at the University of North Carolina (2001), The Jackson Laboratory (2007) and Harvard Institutes of Medicine (2010-2011). He is currently associate editor at Frontiers in Inflammation and Frontiers in Immunology.

Featured publications

Featured Projects

  • Investigació hepática: recerca bàsica i experimental

    Principal investigator: Joan Claria Enrich
    Funder: Generalitat de Catalunya
    Code: 2021-SGR-01323
    Duration: 01/01/2022 - 31/12/2024
  • DECISION (Decompensated cirrhosis: identification of new combinatorial therapies based on systems approaches)

    Principal investigator: Joan Claria Enrich
    Funder: European Commission
    Code: CE-H2020-SC1_2019_2s
    Duration: 01/06/2020 - 31/10/2023
  • MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

    Principal investigator: Joan Claria Enrich, Pere Gines Gibert
    Funder: European Commission
    Code: CE_H2020-SC1_18_1s
    Duration: 01/01/2019 - 31/03/2025
  • Mecanismos moleculares determinantes de la resolución inadecuada de la inflamación en tejido adiposo obeso. Nuevas oportunidades en la prevención de comorbilidades metabolicas.

    Principal investigator: Joan Claria Enrich
    Funder: Ministerio de Economía y Competitividad
    Code: SAF2015-63674-R
    Duration: 01/01/2016 - 31/12/2019
  • Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent mechanisms of disease

    Principal investigator: Joan Claria Enrich
    Funder: Instituto de Salud Carlos III
    Code: PIE14/00045
    Duration: 01/01/2015 - 31/12/2017